SCHEMBL6293109

SCHEMBL6293109

Cc1c(Oc2cccc(Oc3cccc(F)c3)c2)cccc1Oc1cccc(Oc2cccc(F)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.47
SLC6A2 P23975 5/20 0.47
SLC6A3 Q01959 4/20 0.47
HTR1A P08908 3/20 0.47
MRGPRX1 Q96LB2 1/20 0.43
F10 P00742 2/20 0.43
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
ACHE P22303 1/20 0.42
USP2 O75604 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR2A P28223 1/20 0.41
DHODH Q02127 1/20 0.39
GCK P35557 1/20 0.39
MAOB P27338 1/20 0.39
MAPT P10636 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6290387 1.00 SLC6A4 (0.47) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1
SCHEMBL6289773 0.96 SLC6A4 (0.49) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1
SCHEMBL6289868 0.94 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1
SCHEMBL6414751 0.93 SLC6A4 (0.47) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1
SCHEMBL6290694 0.87 SLC6A4 (0.46) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1
SCHEMBL6289211 0.87 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1
SCHEMBL6289809 0.86 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3HTR1AALDH1A1
SCHEMBL6290677 0.86 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3HTR1AALDH1A1
SCHEMBL6936237 0.86 DHFR (0.48) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1
SCHEMBL6422765 0.86 SLC6A2 (0.49) SLC6A4SLC6A2SLC6A3HTR1AMRGPRX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 SLC6A4 1103/4885SLC6A2 2617/4885SLC6A3 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.